Article
Integrative analysis of FAERS, network toxicology, and Mendelian randomization identifies potential targets in paclitaxel-associated systemic sclerosis.
Frontiers in immunology - 1 Jan 2026
Wang Xinfeng, Zhang Chengyan
Abstract excerpt
Systemic sclerosis (SSc) is a rare and complex autoimmune disease characterized by fibrosis of the skin and internal organs as well as vascular abnormalities. Studies have suggested that paclitaxel may induce adverse reactions resembling systemic sclerosis; however, the underlying mechanisms remain not fully understood. We retrieved reports of paclitaxel-associated SSc from the FDA Adverse Event Reporting System...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
